Eocene Ltd. (EOCN)
EOCNNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$2.70
-0.1701 (-5.93%) today
At the close, Nov 10, 4:00 PM ET. After hours $3.00 +20.00%
- Market cap
- $2.60m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- $2.48 to $2.79
- 52-week range
- $2.30 to $12.32
- Average volume
- 17.8k
- Previous close
- $2.87
Financials
No quarterly figures from the source.
News
8 latest- Galmed Pharma Rebrands To EoCene, Debuts EOCN Ticker As GI Expansion Accelerates; Stock Up RTTNews · Sep 9, 2026
- 6 Biotech Stocks In Focus: Modular Medical, Galmed, Pro-Dex, Connect Biopharma & More RTTNews · Sep 3, 2026
- Galemed's First-in-Human Study Validated Colospan Tissue Tech; Stock Up RTTNews · Aug 19, 2026
- Galmed's Aramchol Combo Delivers 3-4-Fold Increase In Prostate Cancer Cell Death; Stock Up RTTNews · Aug 17, 2026
- Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data RTTNews · Jun 12, 2026
- Galmed To Acquire Colospan, Creating GI-Focused Platform; Stock Down RTTNews · Jun 8, 2026
- Galmed To Collaborate With Tel Aviv University For Aramchol In Treating Brain Cancer RTTNews · Apr 15, 2026
- Galmed Shares Surge On Breakthrough Aramchol Formulation RTTNews · Apr 9, 2026
The company
EoCene Ltd. (NASDAQ: EOCN) is a GI-focused medtech and biopharmaceutical company headquartered in Ramat Gan, Israel, dedicated to advancing innovative solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. The Company is building a diversified platform that combines medical devices, therapeutics and enabling technologies to address significant unmet clinical needs and improve patient outcomes. EoCene's wholly owned subsidiary, Colospan Ltd., is a commercial-stage medical device company developing solutions designed to transform postoperative colorectal care. Its flagship product, CG-100, is an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas, offering a less invasive alternative to current surgical practice.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- Middle East
- Website
- galmedpharma.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.